{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:36:24Z","timestamp":1789605384945,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Accurate preoperative diagnosis of nodal status in intrahepatic cholangiocarcinoma (ICC) remains challenging. The objective of the current study was to determine if\u00a0the systemic immune-inflammatory index (SII) was associated with occult nodal disease (OND) among cN0 patients undergoing resection for ICC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients who underwent curative resection for ICC were identified from an international multi-institutional database. A multivariable logistic regression model was used to assess the relationship between SII and OND.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 490 patients who underwent curative resection with lymph node dissection (LND) for cN0 ICC, 135 (27.6%) had OND. Among these individuals, high SII (\u2265738.4) was independently associated with OND (odds ratio [OR], 1.85, 95% confidence interval [CI], 1.18\u20132.92). This association was consistent even among patients with cT1aN0M0 disease (OR, 1.85; 95% CI, 1.19\u20132.88). Interestingly, among patients with high SII and N0\/Nx disease, individuals whose total number of lymph nodes examined (TLNE) was fewer than six had worse 3-year recurrence-free survival (RFS) than patients with a TLNE of six or more (38.8% vs 74.0%; <jats:italic>p\u2009<\/jats:italic>=\u20090.002). In contrast, RFS did not differ among patients with low SII and N0\/Nx disease (TLNE &lt;6 [49.1%] vs \u22656 [62.4%]; <jats:italic>p<\/jats:italic>\u2009=\u20090.099).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>High SII was an independent predictor of OND, even among patients with early-stage disease, suggesting that incorporating SII into preoperative risk assessment may refine staging and guide treatment strategies including the need for neoadjuvant therapy as well as the extent and adequacy of LND.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-025-17781-0","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:42:26Z","timestamp":1752140546000},"page":"7152-7162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Preoperative Systemic Immune-Inflammatory Index Predicts Occult Nodal Disease in Clinically Node-Negative Intrahepatic Cholangiocarcinoma"],"prefix":"10.1245","volume":"32","author":[{"given":"Jun","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Akabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujtaba","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selamawit","family":"Woldesenbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odysseas P.","family":"Chatzipanagiotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Sahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Cauchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Aucejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo P.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia","family":"Rodriguea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Hugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishir K.","family":"Maithel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas Groot","family":"Koerkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irinel","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Kitago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Pulitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Aldrighetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Poultsides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ruzzente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gleisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7994-9870","authenticated-orcid":false,"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"17781_CR1","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00268-019-04966-4","volume":"43","author":"L Wu","year":"2019","unstructured":"Wu L, Tsilimigras DI, Paredes AZ, Mehta R, Hyer JM, Merath K, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy, and overall survival. World J Surg. 2019;43:1777\u201387. https:\/\/doi.org\/10.1007\/s00268-019-04966-4.","journal-title":"World J Surg."},{"key":"17781_CR2","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00432-010-0971-z","volume":"137","author":"AK Singal","year":"2011","unstructured":"Singal AK, Vauthey JN, Grady JJ, Stroehlein JR. Intra-hepatic cholangiocarcinoma\u2014frequency and demographic patterns: thirty-year data from the MD Anderson Cancer Center. J Cancer Res Clin Oncol. 2011;137:1071\u20138. https:\/\/doi.org\/10.1007\/s00432-010-0971-z.","journal-title":"J Cancer Res Clin Oncol."},{"key":"17781_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","volume":"79","author":"European Association for the Study of the Liver","year":"2023","unstructured":"European Association for the Study of the Liver. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol. 2023;79:181\u2013208. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.010.","journal-title":"J Hepatol."},{"key":"17781_CR4","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/bjs.10676","volume":"105","author":"XF Zhang","year":"2018","unstructured":"Zhang XF, Beal EW, Bagante F, Chakedis J, Weiss M, Popescu I, et al. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg. 2018;105:848\u201356. https:\/\/doi.org\/10.1002\/bjs.10676.","journal-title":"Br J Surg."},{"key":"17781_CR5","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s11605-020-04720-5","volume":"25","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras DI, Sahara K, Paredes AZ, Moro A, Mehta R, Moris D, et al. Predicting lymph node metastasis in intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2021;25:1156\u201363. https:\/\/doi.org\/10.1007\/s11605-020-04720-5.","journal-title":"J Gastrointest Surg."},{"key":"17781_CR6","doi-asserted-by":"publisher","first-page":"e1187","DOI":"10.1097\/SLA.0000000000003788","volume":"274","author":"XF Zhang","year":"2021","unstructured":"Zhang XF, Xue F, Dong DH, Weiss M, Popescu I, Marques HP, et al. Number and station of lymph node metastasis after curative-intent resection of intrahepatic cholangiocarcinoma impact prognosis. Ann Surg. 2021;274:e1187\u201395. https:\/\/doi.org\/10.1097\/SLA.0000000000003788.","journal-title":"Ann Surg."},{"key":"17781_CR7","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1245\/s10434-019-07483-9","volume":"26","author":"K Sahara","year":"2019","unstructured":"Sahara K, Tsilimigras DI, Merath K, Bagante F, Guglielmi A, Aldrighetti L, et al. Therapeutic index associated with lymphadenectomy among patients with intrahepatic cholangiocarcinoma: which patients benefit the most from nodal evaluation? Ann Surg Oncol. 2019;26:2959\u201368. https:\/\/doi.org\/10.1245\/s10434-019-07483-9.","journal-title":"Ann Surg Oncol."},{"key":"17781_CR8","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.1245\/s10434-020-09536-w","volume":"28","author":"MC Mason","year":"2021","unstructured":"Mason MC, Massarweh NN, Tzeng CD, Chiang YJ, Chun YS, Aloia TA, et al. Time to rethink upfront surgery for resectable intrahepatic cholangiocarcinoma? Implications from the neoadjuvant experience. Ann Surg Oncol. 2021;28:6725\u201335. https:\/\/doi.org\/10.1245\/s10434-020-09536-w.","journal-title":"Ann Surg Oncol."},{"key":"17781_CR9","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1007\/s00268-019-05365-5","volume":"44","author":"Y Moon","year":"2020","unstructured":"Moon Y, Choi SY, Park JK, Lee KY. Risk factors for occult lymph node metastasis in peripheral non-small cell lung cancer with invasive component size 3 cm or less. World J Surg. 2020;44:1658\u201365. https:\/\/doi.org\/10.1007\/s00268-019-05365-5.","journal-title":"World J Surg."},{"key":"17781_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.clbc.2021.07.006","volume":"22","author":"JB Hammond","year":"2022","unstructured":"Hammond JB, Scott DW, Kosiorek HE, Parnall TH, Gray RJ, Ernst BJ, et al. Characterizing occult nodal disease within a clinically node-negative, neoadjuvant breast cancer population. Clin Breast Cancer. 2022;22:186\u201390. https:\/\/doi.org\/10.1016\/j.clbc.2021.07.006.","journal-title":"Clin Breast Cancer."},{"key":"17781_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.surg.2009.10.008","volume":"147","author":"N Wasif","year":"2010","unstructured":"Wasif N, Faries MB, Saha S, Turner RR, Wiese D, McCarter MD, et al. Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trial. Surgery. 2010;147:352\u20137. https:\/\/doi.org\/10.1016\/j.surg.2009.10.008.","journal-title":"Surgery."},{"key":"17781_CR12","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1245\/s10434-017-6290-8","volume":"25","author":"CM Court","year":"2018","unstructured":"Court CM, Ankeny JS, Sho S, Winograd P, Hou S, Song M, et al. Circulating tumor cells predict occult metastatic disease and prognosis in pancreatic cancer. Ann Surg Oncol. 2018;25:1000\u20138. https:\/\/doi.org\/10.1245\/s10434-017-6290-8.","journal-title":"Ann Surg Oncol."},{"key":"17781_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u20137. https:\/\/doi.org\/10.1038\/nature01322.","journal-title":"Nature."},{"issue":"12","key":"17781_CR14","doi-asserted-by":"publisher","first-page":"7605","DOI":"10.1245\/s10434-022-12058-2","volume":"29","author":"J Toyoda","year":"2022","unstructured":"Toyoda J, Sahara K, Maithel SK, Abbott DE, Poultsides GA, Wolfgang C, Fields RC, He J, Scoggins C, Idrees K, Shen P. Prognostic utility of systemic immune-inflammation index after resection of extrahepatic cholangiocarcinoma: results from the US extrahepatic biliary malignancy consortium. Ann Surg Oncol. 2022;29(12):7605\u201314. https:\/\/doi.org\/10.1245\/s10434-022-12058-2.","journal-title":"Ann Surg Oncol."},{"key":"17781_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gassur.2023.10.002","volume":"28","author":"J Kawashima","year":"2024","unstructured":"Kawashima J, Sahara K, Shen F, Guglielmi A, Aldrighetti L, Weiss M, et al. Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2024;28:18\u201325. https:\/\/doi.org\/10.1016\/j.gassur.2023.10.002.","journal-title":"J Gastrointest Surg."},{"key":"17781_CR16","doi-asserted-by":"publisher","unstructured":"Kawashima J, Endo Y, Woldesenbet S, Khalil M, Akabane M, Cauchy F,\u00a0et al. The influence of tumor burden score and lymph node metastasis on the survival benefit of adjuvant chemotherapy in intrahepatic cholangiocarcinoma.\u00a0Ann Surg Oncol. Published online 17 February 2025. https:\/\/doi.org\/10.1245\/s10434-025-17013-5.","DOI":"10.1245\/s10434-025-17013-5."},{"key":"17781_CR17","doi-asserted-by":"publisher","unstructured":"Kawashima J, Endo Y, Woldesenbet S, Khalil M, Akabane M, Cauchy F,\u00a0et al. \u201cBiological R2\u201d resection for intrahepatic cholangiocarcinoma: identification of patients at risk for poor oncologic outcomes after curative-intent resection.\u00a0HPB Oxford. Published online 20 January 2025. https:\/\/doi.org\/10.1016\/j.hpb.2025.01.006.","DOI":"10.1016\/j.hpb.2025.01.006"},{"key":"17781_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al. The eighth-edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67:93\u20139. https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"CA Cancer J Clin."},{"key":"17781_CR19","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1245\/s10434-024-16455-7","volume":"32","author":"M Akabane","year":"2025","unstructured":"Akabane M, Kawashima J, Woldesenbet S, Macedo AB, Cauchy F, Shen F, et al. Improving recurrence prediction in intrahepatic cholangiocarcinoma: the synergistic impact of the FIB-4 Index and tumor burden score on post-hepatectomy outcomes. Ann Surg Oncol. 2025;32:1011\u201320. https:\/\/doi.org\/10.1245\/s10434-024-16455-7.","journal-title":"Ann Surg Oncol."},{"key":"17781_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/SLA.0000000000004808","volume":"274","author":"M Nagino","year":"2021","unstructured":"Nagino M, DeMatteo R, Lang H, Cherqui D, Malago M, Kawakatsu S, et al. Proposal of a new comprehensive notation for hepatectomy: the \u201cNew World\u201d terminology. Ann Surg. 2021;274:1\u20133. https:\/\/doi.org\/10.1097\/SLA.0000000000004808.","journal-title":"Ann Surg."},{"key":"17781_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg."},{"key":"17781_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/(sici)1097-0258(19990330)18:6<681::aid-sim71>3.0.co;2-r","volume":"18","author":"S van Buuren","year":"1999","unstructured":"van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med. 1999;18:681\u201394. https:\/\/doi.org\/10.1002\/(sici)1097-0258(19990330)18:6%3c681::aid-sim71%3e3.0.co;2-r.","journal-title":"Stat Med."},{"key":"17781_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1001\/jamasurg.2020.1973","volume":"155","author":"DI Tsilimigras","year":"2020","unstructured":"Tsilimigras DI, Sahara K, Wu L, Moris D, Bagante F, Guglielmi A, et al. Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering alternative treatment approaches. JAMA Surg. 2020;155:823\u201331. https:\/\/doi.org\/10.1001\/jamasurg.2020.1973.","journal-title":"JAMA Surg."},{"key":"17781_CR24","doi-asserted-by":"publisher","unstructured":"Lamarca A, Barriuso J, Chander A, McNamara MG, Hubner RA, \u00d3Reilly D,\u00a0et al.\u00a018F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: systematic review and meta-analysis.\u00a0J Hepatol. 2019;71:115\u201329. https:\/\/doi.org\/10.1016\/j.jhep.2019.01.038.","DOI":"10.1016\/j.jhep.2019.01.038"},{"key":"17781_CR25","doi-asserted-by":"publisher","first-page":"e20932","DOI":"10.1097\/MD.0000000000020932","volume":"99","author":"X Huang","year":"2020","unstructured":"Huang X, Yang J, Li J, Xiong Y. Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography\/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: a meta-analysis. Med Baltimore. 2020;99:e20932. https:\/\/doi.org\/10.1097\/MD.0000000000020932.","journal-title":"Med Baltimore."},{"key":"17781_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u201344. https:\/\/doi.org\/10.1038\/nature07205.","journal-title":"Nature."},{"key":"17781_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/0-387-26283-0_5","volume":"130","author":"TL Whiteside","year":"2006","unstructured":"Whiteside TL. The role of immune cells in the tumor microenvironment. Cancer Treat Res. 2006;130:103\u201324. https:\/\/doi.org\/10.1007\/0-387-26283-0_5.","journal-title":"Cancer Treat Res."},{"issue":"5","key":"17781_CR28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/XCS.0000000000001244","volume":"240","author":"AA Khan","year":"2023","unstructured":"Khan AA, Shah SK, Basu S, Alex GC, Liptay MJ, Geissen NM, Seder CW. Increased systemic immune-inflammatory index and association with occult nodal disease in non-small cell lung cancer. J Am College Surg. 2023;240(5):784\u201395. https:\/\/doi.org\/10.1097\/XCS.0000000000001244.","journal-title":"J Am College Surg."},{"key":"17781_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.21037\/hbsn-23-631","volume":"13","author":"P Gavriilidis","year":"2024","unstructured":"Gavriilidis P, Pawlik TM. Inflammatory indicators such as systemic immune inflammation index (SIII), systemic inflammatory response index (SIRI), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) as prognostic factors of curative hepatic resections for hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2024;13:509\u201311. https:\/\/doi.org\/10.21037\/hbsn-23-631.","journal-title":"Hepatobiliary Surg Nutr."},{"key":"17781_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.21037\/hbsn-24-385","volume":"14","author":"J Kawashima","year":"2025","unstructured":"Kawashima J, Endo Y, Rashid Z, Altaf A, Woldesenbet S, Tsilimigras DI, et al. Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine-learning approach. Hepatobiliary Surg Nutr. 2025;14:3\u201315. https:\/\/doi.org\/10.21037\/hbsn-24-385.","journal-title":"Hepatobiliary Surg Nutr."},{"key":"17781_CR31","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.hpb.2020.03.011","volume":"22","author":"DI Tsilimigras","year":"2020","unstructured":"Tsilimigras DI, Moris D, Mehta R, Paredes AZ, Sahara K, Guglielmi A, et al. The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis. HPB Oxford. 2020;22:1667\u201374. https:\/\/doi.org\/10.1016\/j.hpb.2020.03.011.","journal-title":"HPB Oxford."},{"key":"17781_CR32","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.2147\/JIR.S345790","volume":"14","author":"H Lei","year":"2021","unstructured":"Lei H, Xu S, Mao X, Chen X, Chen Y, Sun X, Sun P. Systemic immune-inflammatory index as a predictor of lymph node metastasis in endometrial cancer. J Inflam Res. 2021;14:7131\u201342. https:\/\/doi.org\/10.2147\/JIR.S345790.","journal-title":"J Inflam Res."},{"key":"17781_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3322\/caac.21779","volume":"73","author":"SM Ruff","year":"2023","unstructured":"Ruff SM, Diaz DA, Pitter KL, Hartwell BC, Pawlik TM. Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma. CA Cancer J Clin. 2023;73:346\u201352. https:\/\/doi.org\/10.3322\/caac.21779.","journal-title":"CA Cancer J Clin."},{"key":"17781_CR34","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1245\/s10434-020-09478-3","volume":"28","author":"O Utuama","year":"2021","unstructured":"Utuama O, Permuth JB, Dagne G, Sanchez-Anguiano A, Alman A, Kumar A, et al. Neoadjuvant chemotherapy for intrahepatic cholangiocarcinoma: a propensity score survival analysis supporting use in patients with high-risk disease. Ann Surg Oncol. 2021;28:1939\u201349. https:\/\/doi.org\/10.1245\/s10434-020-09478-3.","journal-title":"Ann Surg Oncol."},{"key":"17781_CR35","doi-asserted-by":"publisher","first-page":"6558","DOI":"10.1245\/s10434-023-13809-5","volume":"30","author":"SK Maithel","year":"2023","unstructured":"Maithel SK, Keilson JM, Cao HST, Rupji M, Mahipal A, Lin BS, et al. NEO-GAP: a single-arm, phase II feasibility trial of neoadjuvant gemcitabine, cisplatin, and nab-paclitaxel for resectable, high-risk intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2023;30:6558\u201366. https:\/\/doi.org\/10.1245\/s10434-023-13809-5.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"17781_CR36","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/ajt.12591","volume":"14","author":"G Sapisochin","year":"2014","unstructured":"Sapisochin G, de Rodr\u00edguezLope C, Gastaca M, de OrtizUrbina J, Suarez MA, Santoyo J, Castroagud\u00edn JF, Varo E, L\u00f3pez-Andujar R, Palacios F, Sanchez Antol\u00edn G. \u201cVery early\u201d intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients? Am J Transplant. 2014;14(3):660\u20137. https:\/\/doi.org\/10.1111\/ajt.12591.","journal-title":"Am J Transplant."},{"key":"17781_CR37","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/hep.28744","volume":"64","author":"G Sapisochin","year":"2016","unstructured":"Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY, et al. Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment. Hepatology. 2016;64:1178\u201388. https:\/\/doi.org\/10.1002\/hep.28744.","journal-title":"Hepatology."},{"key":"17781_CR38","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/lt.25737","volume":"26","author":"E De Martin","year":"2020","unstructured":"De Martin E, Rayar M, Golse N, Dupeux M, Gelli M, Gnemmi V, et al. Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in the setting of cirrhosis. Liver Transpl. 2020;26:785\u201398. https:\/\/doi.org\/10.1002\/lt.25737.","journal-title":"Liver Transpl."},{"key":"17781_CR39","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/lt.26285","volume":"28","author":"T Ito","year":"2022","unstructured":"Ito T, Butler JR, Noguchi D, Ha M, Aziz A, Agopian VG, et al. A 3-decade, single-center experience of liver transplantation for cholangiocarcinoma: impact of era, tumor size, location, and neoadjuvant therapy. Liver Transpl. 2022;28:386\u201396. https:\/\/doi.org\/10.1002\/lt.26285.","journal-title":"Liver Transpl."},{"key":"17781_CR40","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/hep.31077","volume":"72","author":"T Malikowski","year":"2020","unstructured":"Malikowski T, Levy MJ, Gleeson FC, Storm AC, Vargas EJ, Topazian MD, et al. Endoscopic ultrasound\/fine-needle aspiration is effective for lymph node staging in patients with cholangiocarcinoma. Hepatology. 2020;72:940\u20138. https:\/\/doi.org\/10.1002\/hep.31077.","journal-title":"Hepatology."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17781-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17781-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17781-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T14:04:54Z","timestamp":1758549894000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17781-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["17781"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17781-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}